CVS Health Corporation (NYSE:CVS) Shares Bought by Value Partners Investments Inc.

Value Partners Investments Inc. lifted its holdings in shares of CVS Health Corporation (NYSE:CVS - Free Report) by 1,097.1% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,349,421 shares of the pharmacy operator's stock after acquiring an additional 1,236,693 shares during the quarter. CVS Health comprises approximately 7.9% of Value Partners Investments Inc.'s holdings, making the stock its biggest holding. Value Partners Investments Inc. owned approximately 0.11% of CVS Health worth $91,524,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. Hopwood Financial Services Inc. purchased a new stake in shares of CVS Health in the fourth quarter worth about $29,000. McIlrath & Eck LLC lifted its position in CVS Health by 32.6% during the 4th quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator's stock worth $32,000 after acquiring an additional 174 shares in the last quarter. Providence First Trust Co purchased a new position in CVS Health in the 4th quarter worth approximately $42,000. Park Square Financial Group LLC acquired a new stake in CVS Health in the fourth quarter valued at approximately $43,000. Finally, PARK CIRCLE Co raised its stake in shares of CVS Health by 42.9% during the fourth quarter. PARK CIRCLE Co now owns 1,000 shares of the pharmacy operator's stock valued at $45,000 after purchasing an additional 300 shares during the period. 80.66% of the stock is owned by hedge funds and other institutional investors.

CVS Health Trading Down 1.7%

NYSE CVS opened at $66.44 on Thursday. The company has a debt-to-equity ratio of 0.77, a quick ratio of 0.63 and a current ratio of 0.82. CVS Health Corporation has a one year low of $43.56 and a one year high of $72.51. The company has a 50-day simple moving average of $64.81 and a 200-day simple moving average of $60.62. The firm has a market capitalization of $84.05 billion, a PE ratio of 15.86, a price-to-earnings-growth ratio of 0.97 and a beta of 0.56.

CVS Health (NYSE:CVS - Get Free Report) last posted its earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 EPS for the quarter, beating the consensus estimate of $1.62 by $0.63. CVS Health had a return on equity of 10.59% and a net margin of 1.39%. The company had revenue of $94.59 billion during the quarter, compared to analyst estimates of $93.07 billion. During the same period in the prior year, the company earned $1.31 earnings per share. The business's revenue was up 7.0% compared to the same quarter last year. On average, equities analysts forecast that CVS Health Corporation will post 5.89 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on CVS shares. Wells Fargo & Company reaffirmed an "overweight" rating and set a $84.00 price target (up from $76.00) on shares of CVS Health in a report on Tuesday, May 6th. Truist Financial lifted their target price on CVS Health from $82.00 to $84.00 and gave the stock a "buy" rating in a research report on Monday, May 12th. Barclays set a $79.00 price target on CVS Health and gave the company an "overweight" rating in a report on Monday, June 2nd. Mizuho lifted their price objective on CVS Health from $70.00 to $76.00 and gave the stock an "outperform" rating in a report on Wednesday, April 9th. Finally, Cowen reiterated a "buy" rating on shares of CVS Health in a research note on Monday, May 5th. Two investment analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat, CVS Health presently has an average rating of "Moderate Buy" and an average price target of $74.75.

Insider Buying and Selling

In other news, Director Guy P. Sansone bought 1,570 shares of CVS Health stock in a transaction on Thursday, June 5th. The stock was purchased at an average cost of $63.70 per share, with a total value of $100,009.00. Following the purchase, the director now directly owns 12,007 shares of the company's stock, valued at approximately $764,845.90. This trade represents a 15.04% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Corporate insiders own 1.22% of the company's stock.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.